News
ZIP Solutions advances Click-CAR towards future leukaemia therapies
The BIAT Group subsidiary (BME ticker BST) has published a study demonstrating the modular assembly of CAR T cells. The findings support the development of Click-CAR for future therapies targeting
Biobide has grown its ecotoxicology service line into a more comprehensive GLP-certified testing platforms — now spanning terrestrial, sediment, avian,
The zebrafish Light-Dark Transition Test, validated across four independent labs including Biobide, detected 93% of DNT-positive compounds and 100%
Biobide's aquatic toxicity data will also be available through AsedaSciences' AI 3RnD platform into an environment alongside study ordering, visualization,
NIH study ranks zebrafish as the most sensitive DNT assay of 17 tested — Biobide contributed the data.
